Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 2004;89:502-504; doi:10.1136/adc.2003.028548
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Archives of Disease in Childhood 2004;89:502-504
© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health

LEADING ARTICLE

Diabetes

Understanding the rising incidence of type 2 diabetes in adolescence

J Weill1, S Vanderbecken3, P Froguel2

1 Paediatric Endocrine Unit, University Hospital, Lille, France
2 Institute of Biology–CNRS UMR 8090, Institut Pasteur de Lille, Lille, France
3 Paediatric Department, Saint-François d’Assise Foundation, Saint-Denis, Réunion Island, France

Correspondence to:
Correspondence to:
Prof. P Froguel
Institute of Biology–CNRS 8090, Institut Pasteur de Lille, 1 rue Calmette, 59 000 Lille, France; philippe.froguel@mail-good.pasteur-lille.fr


A focus on its epidemiology, pathology, and therapeutic consequences

Keywords: epidemiology; pathology; type 2 diabetes; adolescence

The first 150 words of the full text of this article appear below.

The definition of diabetes mellitus (DM) was recently changed by the American Diabetes Association to a fasting plasma glucose value of at least 126 mg/dl (6.9 mmol/l), on the basis of increased risk of the complication of retinopathy.1 It has been estimated that worldwide approximately 154 million people have diabetes,2 with up to one third of the cases remaining undiagnosed in developed countries such as the USA.3 Its human cost is considerable with morbidity from retinopathy, neuropathy, renal failure, and vascular disease, in addition to the socioeconomic burden. Additional lifetime health costs attributable to DM have been estimated at £19 649 per affected individual in the UK.4

Since the introduction of insulin therapy, a clear distinction has been established between the form of DM where insulin is immediately needed (type 1 or insulin dependent DM), and that where there is a danger of hypoglycaemia, where insulin therapy represents a . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Haga, S. B., Terry, S. F. (2009). Ensuring the Safe Use of Genomic Medicine in Children. CLIN PEDIATR 48: 703-708 [Abstract]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs